Halozyme Therapeutics To Participate In Upcoming Healthcare Conferences

Halozyme Therapeutics To Participate In Upcoming Healthcare Conferences

SAN DIEGO, May 29, 2018 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies will participate in two upcoming investor conferences. Dr. Helen Torley, president and chief executive officer will represent Halozyme in a question and answer session